Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1478 of 5804
-
Can a smartphone app with rewards boost opioid treatment success after an emergency?
Disease control TerminatedMillions of people in the US misuse opioids each year. Medication assisted treatment (MAT) for opioid use disorder (OUD) is highly efficacious, but only a fraction of OUD persons access MAT, and treatment non-adherence is common and associated with poor outcomes. This project wil…
Phase: NA • Sponsor: Q2i, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Apple watch could spot hidden heart condition in seniors
Diagnosis CompletedThis is a randomized controlled trial evaluating atrial fibrillation (AF) detection through smartwatch-based screening in high-risk patients using an Apple Watch with integrated PPG and ECG functions.
Phase: NA • Sponsor: Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) • Aim: Diagnosis
Last updated Jun 26, 2026 18:44 UTC
-
New hope for hard-to-treat bladder cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis substudy is part of an umbrella platform study which is designed to evaluate investigational agents with or without pembrolizumab in participants with urothelial carcinoma who are in need of new treatment options. Substudy 04A will enroll participants with locally advanced o…
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for liver metastases: Y-90 radiation before surgery may boost candidacy
Disease control Recruiting nowA prospective, interventional study evaluating the safety of Y-90 TARE for tumor control of the right side and induction of left liver hypertrophy as part of a planned single-stage or two-stage hepatectomy for patients with CLM and insufficient FLR at the time of presentation.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects, and best dose of entinostat and ZEN003694 in treating patients with solid tumors that have spread to other places in the body (advanced) or does not respond to treatment (refractory). Entinostat is in a class of drugs called h…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
10-Minute Finger-Prick test could revolutionize heart attack diagnosis
Diagnosis OngoingIn this observational research project the investigators wish to test new technologies that could allow them to either detect or rule out heart attacks earlier. Currently, when a patient attends the Emergency Department with symptoms that could be due to a heart attack, the pati…
Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Immunotherapy shot could replace IV drip for advanced head and neck cancer
Disease control CompletedThe purpose of this phase I clinical study was to evaluate the safety and tolerability of JS001sc monotherapy and combination with gemcitabine and cisplatin (GP) in patients with Advanced nasopharyngeal carcinoma.
Phase: PHASE1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can online peer support help women with HIV and trauma stay on track?
Disease control Recruiting nowA two-arm RCT will be conducted to test the efficacy of Women SHINE, a web-based trauma-informed peer navigation-social support intervention (Figure 2). A total of 360 women living with HIV/AIDS (WLHA) with a history of adulthood interpersonal violence who have been prescribed AR…
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Mind-Controlled hand therapy shows promise for spinal cord injury recovery
Disease control CompletedThe goal of this clinical trial is to validate the efficacy of a Brain-Computer Interface (BCI)-based intervention for hand motor recovery in subacute cervical spinal cord injured (SCI) patients during rehabilitation. The study will provide evidence for the clinical/neurophysiolo…
Phase: NA • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC
-
New immunotherapy DF9001 targets Hard-to-Treat cancers
Disease control CompletedDF9001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell activation signals to specific receptors on cancer cells. The study will occur in two phases. The first phase will be a dose escalation phase, enrolling patients with various types of solid …
Phase: PHASE1, PHASE2 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Brain pressure monitor could boost recovery after major bleed
Disease control CompletedSpontaneous cerebral hemorrhage (SICH) is a hemorrhage caused by the rupture of a blood vessel within the brain parenchyma that is non-traumatic. Its rapid onset and dangerous condition seriously threaten human health; it accounts for about 15% of strokes and 50% of stroke-relate…
Phase: NA • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 26, 2026 15:06 UTC
-
New drug could ease teen IBS constipation pain
Symptom relief OngoingThis is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of tenapanor (25 mg and 50 mg) in pediatric patients (≥12 and \<18 years old) with IBS-C when administered twice daily (BID) for 12 consecutive weeks.
Phase: PHASE3 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New combo therapy targets hard-to-treat lung cancer in chinese patients
Disease control OngoingThis is an open-label, interventional, multiple-center, exploratory Phase II study sponsored by AstraZeneca Investment(China)Co., LTD. to evaluate the efficacy and safety of Savolitinib combine with Durvalumab in Chinese EGFR wild-type locally advanced or metastatic NSCLC patient…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New sensor could save replanted limbs by spotting trouble early
Knowledge-focused OngoingInvestigators will test if changes in CO2 is detected postoperatively in ischemic tissue in a replanted extremity of a traumatically amputated upper or lower extremity. IscAlert is measuring continuously CO2 in muscular and subcutaneous tissue. IscAlert is inserted distal to the …
Phase: NA • Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New hope for advanced cancer? experimental drug ZGGS18 enters human trials
Disease control Recruiting nowA clinical study to assess dose escalation, tolerance, safety, pharmacokinetics, and multi cohort expansion of ZGGS18 in patients with advanced solid tumors
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Brain zaps boost walking and thinking in Parkinson's patients
Symptom relief CompletedThis study aimed to evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) applied to the left dorsolateral prefrontal cortex on cognitive function and dual-task performance in individuals with Parkinson's disease. Participants completed ten rTMS sessions ove…
Phase: NA • Sponsor: University of Gaziantep • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New hope for kids with rare lung condition: macitentan shows promise in small study
Disease control CompletedThe purpose of this study is to evaluate the effect of macitentan on hemodynamic measures at Week 24 in pediatric populations.
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can tailored rehab after ACL surgery keep athletes safer?
Prevention Recruiting nowFollowing reconstruction of the anterior cruciate ligament (ACL), a standardized rehabilitation protocol is carried out by a physiotherapist. In France, a well-established rehabilitation consensus guides the first phase of 3 months postoperatively and patient compliance is genera…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Steroid shot before angioplasty may limit heart damage
Disease control CompletedThe overall primary objective of the PULSE-MI trial is to test the hypothesis that administration of single-dose glucocorticoid pulse therapy in the pre-hospital setting reduces final infarct size in patients with ST-segment elevation myocardial infarction (STEMI) treated with pr…
Phase: PHASE2 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo pill aims to halt liver scarring in NASH patients
Disease control CompletedA study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatohepatitis (NASH).
Phase: PHASE2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC